We hypothesized that combination of multi-kinase inhibition and PP2A reactivation would result in such a broad-spectrum inhibition of serine/threonine phosphorylation that cancer cells could not anymore use phosphorylation-dependent signaling rewiring as an escape mechanism. Here, PTPA is linked to cancer.